Full video transcriptClick to expand
Auto-generated transcript of @glowwithtae's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.
- 0:00I asked someone who has lost 50 LBs
- 0:02with the help of a GOP one
- 0:03and has been maintaining without a GOP one.
- 0:06Here are three habits that I still keep,
- 0:08even the one no longer on one.
- 0:09I'll eat high protein, high fiber.
- 0:11I also don't force myself to eat.
- 0:13Like when I'm full and I feel like I'm full, I just stop.
- 0:17And then I still make sure I get my vitamins,
- 0:19my supplements, and all the things
- 0:20that I will still use on a GOP one.
- 0:22These changes I still have been able to maintain
- 0:25without medication for the last couple of months.
- 0:28So I feel like they are still helping.
- 0:30Love about these habits is that they are not specific.
- 0:33They're just habits that can help you in any phase in life,
- 0:36whether you're on a medication or not.
GLP-1 habit maintenance after stopping: what holds up
Quick answer
GLP-1 receptor agonists suppress appetite and slow gastric emptying through pharmacological mechanisms that reverse after discontinuation, making post-medication weight maintenance behaviorally and biologically harder than the video suggests. High protein and high fiber dietary patterns are evidence-supported strategies for weight maintenance and can reasonably be carried forward from a GLP-1 treatment period. However, published data including Wilding et al. (2022, NEJM) consistently show substantial weight regain in most patients within one year of stopping these medications, so short-term anecdotal maintenance accounts should be interpreted cautiously.
Video review standard
Clinical fact-check snapshot
FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.
Evidence signal
Source-backed review
Regulatory reality
Access rules depend on the compound and patient situation
Safety screen
Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.
This page currently connects to 7 source-backed evidence items through visible references or structured citation data.
PubMed evidence trail
Research sources used to frame this page
For GLP-1 habit maintenance after stopping: what holds up, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
Once-Weekly Semaglutide in Adults with Overweight or Obesity
Primary STEP 1 trial source for semaglutide weight-management efficacy and adverse-event context.
PubMed
Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance
Used for maintenance, discontinuation, and weight-regain discussions after semaglutide response.
PubMed
Efficacy of GLP-1 Receptor Agonists on Weight Loss, BMI, and Waist Circumference
A broad meta-analysis anchor for GLP-1 weight-loss effect and class-level comparisons.
PubMed
Discontinuing glucagon-like peptide-1 receptor agonists and body habitus
Used for pages discussing stopping therapy, weight regain, and long-term planning.
PubMed
Video claim decision path
Turn the claim into a safer next question
Direct answer
GLP-1 habit maintenance after stopping: what holds up should be treated as a claim to verify, then compared with evidence, safety context, and a provider review path.
Evidence check
Social clips are useful prompts, but they rarely show the full evidence base, contraindications, or dosing context.
Safety check
A viral claim can miss patient-specific risks, medication interactions, legal access, and source quality.
Next step
If the claim matches your goal, use the get-started flow to move from curiosity into a supervised prescription review.
Helpful context before the funnel
Page-specific review note
What this exact clip is really saying
This FormBlends review is specific to "GLP-1 habit maintenance after stopping: what holds up" from Tae | Your Wellness Bestie 🌷. We read the clip as a GLP-1 social video fact-checks claim about GLP-1 social video fact-checks, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: GLP-1 receptor agonists suppress appetite and slow gastric emptying through pharmacological mechanisms that reverse after discontinuation, making post-medication weight maintenance behaviorally and biologically harder than the video suggests.
The reason this review is not generic is the source wording and the canonical claim label "glp1 these habits i ve picked up from being on a g l p still play." In this clip, the useful excerpt is: "I asked someone who has lost 50 LBs with the help of a GOP one and has been maintaining without a GOP one." That wording changes the review because it points to GLP-1 social video fact-checks evidence, safety, and patient-fit context, not a one-size-fits-all protocol.
The source trail for this page is checked against Once-Weekly Semaglutide in Adults with Overweight or Obesity (2021), Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance (2021), and Effect of Weekly Subcutaneous Semaglutide vs Daily Liraglutide on Body Weight (2022), plus the creator's own wording. GLP-1 social video fact-checks decisions still need an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.
Claim verdict
The useful answer behind this video
This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.
Claim being checked
GLP-1 receptor agonists suppress appetite and slow gastric emptying through pharmacological mechanisms that reverse after discontinuation, making post-medication weight maintenance behaviorally and biologically harder than the video suggests.
FormBlends verdict
GLP-1 social video fact-checks evidence, safety, and patient-fit context
Evidence strength
Source-backed review with clinical or regulatory citations.
Patient-safe next step
Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.
What to do with this video
Use the clip as a claim to verify, not a treatment plan
What it helps with
- GLP-1 receptor agonists suppress appetite and slow gastric emptying through pharmacological mechanisms that reverse after discontinuation, making post-medication weight maintenance behaviorally and biologically harder than the video suggests. High protein and high fiber dietary patterns are evidence-supported strategies for weight maintenance and can reasonably be carried forward from a GLP-1 treatment period. However, published data including Wilding et al. (2022, NEJM) consistently show substantial weight regain in most patients within one year of stopping these medications, so short-term anecdotal maintenance accounts should be interpreted cautiously.
- Wilding et al. (2022, NEJM) found participants regained approximately two-thirds of lost weight within one year of stopping semaglutide, even with lifestyle counseling.
- Higher protein diets preserve lean mass and improve satiety: a 2020 meta-analysis in Nutrients found consistent benefits for weight maintenance across dietary patterns.
What it may miss
- It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
- Compound access, legal status, and product quality still need a separate safety check.
- Social video captions rarely show the full evidence base behind a claim.
Best next step
Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.
Start provider reviewWhat You'll Learn
- Wilding et al. (2022, NEJM) found participants regained approximately two-thirds of lost weight within one year of stopping semaglutide, even with lifestyle counseling.
- Higher protein diets preserve lean mass and improve satiety: a 2020 meta-analysis in Nutrients found consistent benefits for weight maintenance across dietary patterns.
- Dietary fiber slows digestion and supports satiety hormones: Barber et al. (2019, Nutrients) linked higher fiber intake to reduced postprandial hunger independent of caloric intake.
- GLP-1 drugs slow gastric emptying and suppress appetite centrally. Both effects reverse after stopping the medication, making hunger cue strategies less reliable than they are during treatment.
- Rubino et al. (2023, Obesity) documented that appetite-related quality of life scores dropped significantly within months of semaglutide discontinuation, reflecting a real biological shift, not just psychology.
- A few months of post-discontinuation maintenance is encouraging but not conclusive. Most clinical studies define meaningful maintenance as sustained over 12 to 24 months.
- Anyone stopping a GLP-1 medication should do so with clinical supervision, as weight regain patterns and individual health contexts vary significantly.
Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.
What did @glowwithtae actually say?
The creator interviewed someone who lost 50 pounds on a GLP-1 medication and has since stopped taking it. That person said they kept three habits: eating high protein and high fiber, not forcing themselves to eat past fullness, and continuing vitamins and supplements. The claim is that these habits have helped them maintain weight loss "for the last couple of months" without medication.
This is a personal experience account, not a protocol. The creator is clear about that, noting these are "not specific" habits that can apply "in any phase in life." That framing matters because it keeps the claims reasonable and avoids overpromising.
Does the science back this up?
Largely, yes, with one important asterisk on the hunger cue piece.
High protein diets have solid evidence behind them for weight maintenance. A 2020 meta-analysis by Koliaki et al. in Nutrients found that higher protein intake preserves lean mass during weight loss and supports satiety long-term. Fiber intake is similarly well-supported: a 2019 review by Barber et al. in Nutrients linked dietary fiber to improved satiety hormones and lower postprandial glucose responses, both relevant after stopping a GLP-1 drug.
The hunger cue piece is more complicated. GLP-1 medications work partly by slowing gastric emptying and suppressing appetite centrally. When you stop the drug, those effects go away. Research from Wilding et al. (2022, New England Journal of Medicine) showed that one year after stopping semaglutide, participants regained about two-thirds of their lost weight, and hunger returned. Relying on "feeling full" as a maintenance strategy post-GLP-1 is not as straightforward as the video implies.
What did they get wrong (or right)?
They got the protein and fiber advice right. That is genuinely good, evidence-supported guidance regardless of medication status.
The hunger cue advice deserves more nuance than it gets here. Saying "when I'm full, I just stop" sounds simple, but after stopping a GLP-1, the appetite suppression that made that easy is gone. The stomach empties faster again, and hunger hormones like ghrelin rebound. A 2023 study by Rubino et al. in Obesity confirmed that appetite-related quality of life scores dropped significantly after semaglutide discontinuation. Listening to hunger cues is still a reasonable mindfulness habit, but the video makes it sound frictionless when the biology often works against it.
The vitamins and supplements claim is unverifiable. There is no stated rationale for which supplements or why. Some GLP-1 users do have reduced micronutrient intake due to eating less, so continuing supplements can make sense, but without specifics this is not something we can evaluate or endorse.
What should you actually know?
GLP-1 medications change appetite biology while you take them. When you stop, that biology shifts back. Habits alone rarely fully compensate for that shift, which is why the clinical literature consistently shows significant weight regain after discontinuation for most people.
That does not mean habits are useless. High protein intake and fiber are among the most evidence-backed dietary strategies for weight maintenance independent of any medication. If someone coming off a GLP-1 builds those habits during treatment, they are in a better position than someone who did not. But "a couple of months" of maintenance is a short window. The real test is 12 to 24 months out.
Anyone considering stopping a GLP-1 should talk to their prescribing clinician first. Weight regain after discontinuation is common and not a personal failure. It reflects the pharmacology of the drug, not a lack of discipline.
Interested in GLP-1 or peptide therapy?
Get matched with licensed-provider review to help decide if it is right for you.
About the Creator
Tae | Your Wellness Bestie 🌷 · TikTok creator
6.8K views on this video
these habits I’ve picked up from being on a G L P , still play a part in my day to day life even after! #glp #maintenance #glpmaintenance
Frequently asked questions
Quick answers based on this video and our medical team review.
What does the video say about wilding et al. (2022, nejm) found participants regained approximately two-thirds?
Wilding et al. (2022, NEJM) found participants regained approximately two-thirds of lost weight within one year of stopping semaglutide, even with lifestyle counseling.
What does the video say about higher protein diets preserve lean mass?
Higher protein diets preserve lean mass and improve satiety: a 2020 meta-analysis in Nutrients found consistent benefits for weight maintenance across dietary patterns.
What does the video say about dietary fiber slows digestion?
Dietary fiber slows digestion and supports satiety hormones: Barber et al. (2019, Nutrients) linked higher fiber intake to reduced postprandial hunger independent of caloric intake.
What does the video say about glp-1 drugs slow gastric emptying?
GLP-1 drugs slow gastric emptying and suppress appetite centrally. Both effects reverse after stopping the medication, making hunger cue strategies less reliable than they are during treatment.
What does the video say about rubino et al. (2023, obesity) documented?
Rubino et al. (2023, Obesity) documented that appetite-related quality of life scores dropped significantly within months of semaglutide discontinuation, reflecting a real biological shift, not just psychology.
What does the video say about a few months of post-discontinuation maintenance?
A few months of post-discontinuation maintenance is encouraging but not conclusive. Most clinical studies define meaningful maintenance as sustained over 12 to 24 months.
Sources & references
Citations extracted from our medical team's review. Click any citation to search PubMed.
Read More on This Topic
Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.
Not medical advice. This video was made by Tae | Your Wellness Bestie 🌷, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.